MedPath

Comparison Between Oral and Enema of Chloral Hydrate

Not Applicable
Completed
Conditions
Congenital Cataract
Interventions
Registration Number
NCT03242629
Lead Sponsor
Sun Yat-sen University
Brief Summary

To compare the clinical sedative effect and safety using 10% chloral hydrate during ophthalmic examinations for oral vs enema group.The patients were randomly divided into two groups (oral group and enema group) using a computer random number generator with a 1:1 allocation (simple randomization, odd number for oral group and even number for enema group).

Detailed Description

To compare the clinical sedative effect and safety using 10% chloral hydrate during ophthalmic examinations for oral vs enema group.The patients were randomly divided into two groups (oral group and enema group) using a computer random number generator with a 1:1 allocation (simple randomization, odd number for oral group and even number for enema group).One hundred and twenty children aged from 3 to 36 months (5-15 kg) scheduled to ophthalmic examinations were randomly sedated by oral chloral hydrate(80 mg×kg-1, n = 60) or enema chloral hydrate(80 mg×kg-1, n = 60). The primary endpoint was successful sedation to complete the examinations including slit-lamp photography, tonometry, anterior segment analysis, and refractive error inspection. The secondary endpoints included onset time, duration of examination, recovery time, discharge time, any side effects during examination, and within 48 h after discharge.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • diagnosed with congenital cataract aged from 3 to 36 months weight from 5 to 15 kg with American Society of Anesthesiologists (ASA) physical status 1-2
Exclusion Criteria
  • with gastro-esophageal reflux, nausea and vomiting, apnea in the past 3 months recent pneumonia exacerbation of asthma, bronchitis and upper respiratory tract infection bradycardia, and facial abnormalities, allergy to chloral hydrate, weight <2 or >20 kg .

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
oral grouporal chloral hydrate-
enema groupenema chloral hydrate-
Primary Outcome Measures
NameTimeMethod
Demography (age, sex, weight, laterality and medical history)baseline

The demography of cataract and healthy children were recorded by using a semi-structured questionnaire

Secondary Outcome Measures
NameTimeMethod
Side effectthe following 48 hour after using the drug

record the following symptom: Vomit after administration、Cough、SpO2 \< 95%、SpO2 \< 90%、New vomiting、Resume normal activity over 8 hour、Poor appetite、Altered bowel habit

the time of Sleepiness:Onset time (min)baseline
the time of Sleepiness:Duration of examination (min)baseline
the time of Sleepiness:Recovery time (min)baseline
© Copyright 2025. All Rights Reserved by MedPath